Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Neomycin Sulfate Patent Expiration

Neomycin Sulfate was first introduced by Pharmacia And Upjohn Co in its drug Mycifradin on Approved Prior to Jan 1, 1982. 12 different companies have introduced drugs containing Neomycin Sulfate.


About Veterinary Neomycin Sulfate

Neomycin Sulfate is used in drugs marketed by 6 different companies: Phibro Animal Health Corp, Huvepharma Eood, Bimeda Animal Health Limited, Zoetis Inc, Medpharmex Inc, Sparhawk Laboratories Inc.

Other drugs containing Neomycin Sulfate are: Biosol liquid , Neo 200 oral solution , Neo sol 50 , Neomed soluble powder

Neomycin Sulfate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Neomycin Sulfate Generic API Manufacturers

Several generic applications have been filed for Neomycin Sulfate. The first generic version for Neomycin Sulfate was by Teva Pharmaceuticals Usa Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Chartwell Molecular Holdings Llc and was approved on Jun 10, 2016.

Given below is the list of companies who have filed for Neomycin Sulfate generic, along with the locations of their manufacturing plants worldwide.